Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Top 5 Milestones in Ophthalmology History
In this article, we explore five significant milestones in the history of ophthalmology that have shaped the way we approach eye health and treatment. The ancient Egyptians, known for their advanced civilization and remarkable contributions to various fields, including medicine,…
FDA Calls for Study on Aldeyra’s Reproxalap in DED
Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for reproxalap, an investigational drug candidate designed for the treatment of dry eye disease.…
Study Reveals Why People with Albinism Have Poor Vision
People with albinism often have poor vision. A new study from the Netherlands Institute for Neuroscience reveals the underlying cause. In Europe, albinism occurs in 1 in 20,000 individuals. However, in some populations, it is much more common, affecting 1…
Reviving Hope for Amblyopia: Late-Stage Treatment
In children with amblyopia, often referred to as “lazy eye,” one eye exhibits weaker vision than the other due to various factors. This weaker eye may struggle with focusing, misalignment due to strabismus, or vision obstruction from conditions like cataracts…
Scientists Innovate Tech for Ischemic Retinopathy Treatment
Professor Byoung Heon Kang and his research team at the Department of Biological Sciences at Ulsan National Institute of Science and Technology (UNIST), in collaboration with Professor Dong Ho Park’s team at Kyungpook National University Hospital, have developed a novel…
UCL-Moorfields Eye Hospital Secures £5M for Research Center
The Sir Jules Thorn Charitable Trust has allocated £5 million towards the establishment of a research center within Oriel, the collaborative initiative between UCL and Moorfields Eye Hospital aimed at advancing eye health. Partnering with Moorfields Eye Charity and Moorfields…
New Experimental Drug Shows Promise in Treating DME
A recent study published in Nature Medicine has unveiled promising insights into a potential breakthrough in the treatment of Diabetic Macular Edema (DME). The study suggests that an experimental drug, part of a new class of therapeutics called “senolytics,” could…
Toku Granted CE and UKCA Marks for CLAiR Technology
Toku announced the acquisition of the CE Mark in Europe and UKCA certification in the United Kingdom for its patented CLAiR technology. This innovation offers a non-invasive method for assessing the risk of cardiovascular disease (CVD) directly at the point…
Perfluorohexyloctane Drops Help Alleviate Dry Eye
According to recent research, perfluorohexyloctane eye drops (SHR8058) demonstrated significant improvement in both the signs and symptoms of dry eye disease (DED) linked to meibomian gland dysfunction (MGD) with rapid effectiveness in Chinese patients. The findings showed that the perfluorohexyloctane…
An Overview of Horner Syndrome
Horner syndrome is a relatively rare disorder characterized by a constricted pupil (miosis), drooping of the upper eyelid (ptosis), absence of sweating of the face (anhidrosis), and sinking of the eyeball into the bony cavity that protects the eye (enophthalmos).…